Photo of Michael D. Shapiro, D.O.

Michael D. Shapiro D.O.

Dr. Shapiro is director of OHSU’s Cardiac MRI an CT program and is board certified in Cardiology, Cardiovascular CT (imaging), and Lipidology (cholesterol). His clinical expertise includes:

Genetic and acquired disorders of cholesterol and triglycerides Atherosclerosis Imaging (Non-invasive imaging of the heart arteries) Genetic predisposition to early heart attacks Cardiovascular risk assessment in apparently healthy individuals Clinical trials of new cholesterol and triglyceride lowering drugs

Read more
  • Residency:

    • Internal Medicine, Mount Sinai/Beth Israel Medical Center, New York, N.Y.
  • Fellowship:

    • Cardiovascular Medicine, Mount Sinai/Beth Israel Medical Center, New York, N.Y.
  • Certifications:

    • American Board of Internal Medicine - Cardiovascular Diseases (2006, 2015)

Publications

  • "Brief commentary : Marijuana and cardiovascular disease—what should we tell patients?" Annals of internal medicine  In: , Vol. 170, No. 2, 15.01.2019, p. 119-120.
  • "Biologic bases of residual risk of cardiovascular events : A flawed concept." European journal of preventive cardiology  In: , Vol. 25, No. 17, 01.11.2018, p. 1831-1835.
  • "Predicting hypertriglyceridemic pancreatitis - Not so fast!" Endocrine Practice  In: , Vol. 24, No. 5, 01.05.2018, p. 495-497.
  • "Diagnosing resistance to a proprotein convertase subtilisin/kexin type 9 inhibitor." Annals of Internal Medicine  In: , Vol. 168, No. 5, 06.03.2018, p. 376-379.
  • "“Taking a look under the hood”—Imaging the phenotypic heterogeneity of familial hypercholesterolemia." Journal of Clinical Lipidology  In: , 01.01.2018.
  • "“Taking a look under the hood”—imaging the phenotypic heterogeneity of familial hypercholesterolemia." Journal of Clinical Lipidology  In: , 01.01.2018.
  • "Medication-based versus target-based lipid management." Journal of Diabetes  In: , 01.01.2018.
  • "Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry." Atherosclerosis  In: , Vol. 267, 01.12.2017, p. 19-26.
  • "Risk Factors for Mortality Among Individuals With Peripheral Arterial Disease." American Journal of Cardiology  In: , Vol. 120, No. 5, 01.09.2017, p. 862-867.
  • "Quantifying sociodemographic and income disparities in medical therapy and lifestyle among symptomatic patients with suspected coronary artery disease : A cross-sectional study in North America." BMJ Open  In: , Vol. 7, No. 9, e016364, 01.09.2017.
  • "Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins." The Journal of clinical endocrinology and metabolism  In: , Vol. 102, No. 9, 01.09.2017, p. 3340-3348.
  • "Application of PCSK9 inhibitors in practice : Challenges and opportunities." Circulation Research  In: , Vol. 121, No. 5, 01.08.2017, p. 499-501.
  • "Setting the Agenda for Preventive Cardiology." Circulation Research  In: , Vol. 121, No. 3, 21.07.2017, p. 211-213.
  • "Dyslipidaemia : The PCSK9 adventure-humanizing extreme LDL lowering." Nature Reviews Cardiology  In: , Vol. 14, No. 6, 01.06.2017, p. 319-320.
  • "Evolocumab and clinical outcomes in patients with cardiovascular disease." New England Journal of Medicine  In: , Vol. 376, No. 18, 04.05.2017, p. 1713-1722.
  • "Discordant response of low-density lipoprotein cholesterol and lipoprotein(a) levels to monoclonal antibodies targeting proprotein convertase subtilisin/kexin type 9." Journal of Clinical Lipidology  In: , 13.01.2017.
  • "Triglycerides, atherosclerosis, and cardiovascular outcome studies : Focus on omega-3 fatty acids." Endocrine Practice  In: , Vol. 23, No. 1, 01.01.2017, p. 100-112.
  • "Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease." F1000Research  In: , Vol. 6, 134, 2017.
  • ""Mutation-negative" familial hypercholesterolemia-When negative is positive." Journal of Clinical Lipidology  In: , 2017.
  • "PCSK9 and atherosclerosis - lipids and beyond." Journal of Atherosclerosis and Thrombosis  In: , Vol. 24, No. 5, 2017, p. 462-472.
  • "Applications of Advanced Imaging in Cardiac Electrophysiology." Current Treatment Options in Cardiovascular Medicine  In: , Vol. 18, No. 11, 66, 01.11.2016.
  • "Economic outcomes with anatomical versus functional diagnostic testing for coronary artery disease." Annals of Internal Medicine  In: , Vol. 165, No. 2, 19.07.2016, p. 94-102.
  • "Association of early stress testing with outcomes for emergency department evaluation of suspected acute coronary syndrome." Critical Pathways in Cardiology  In: , Vol. 15, No. 2, 01.06.2016, p. 60-68.
  • "Treatment gaps in adults with heterozygous familial hypercholesterolemia in the United States." Circulation: Cardiovascular Genetics  In: , Vol. 9, No. 3, 01.06.2016, p. 240-249.
  • "PCSK9 Association With Lipoprotein(a)." Circulation Research  In: , 29.04.2016.
  • "US physician practices for diagnosing familial hypercholesterolemia : Data from the CASCADE-FH registry." Journal of Clinical Lipidology  In: , 11.03.2016.
  • "From Lipids to Inflammation : New Approaches to Reducing Atherosclerotic Risk." Circulation Research  In: , Vol. 118, No. 4, 19.02.2016, p. 732-749.
  • "Comparison of the HEART and TIMI risk scores for suspected acute coronary syndrome in the emergency department." Critical Pathways in Cardiology  In: , Vol. 15, No. 1, 2016, p. 1-5.
  • "Role of Computed Tomography in Assessment of the Thoracic Aorta." Current Treatment Options in Cardiovascular Medicine  In: , Vol. 17, No. 8, 35, 23.08.2015.
  • "Coronary Artery Anomalies : a Pictorial Review." Current Cardiovascular Imaging Reports  In: , Vol. 8, No. 7, 18.07.2015.

Additional information

Edit profile